Ignite Creation Date:
2024-05-06 @ 6:38 PM
Last Modification Date:
2024-10-26 @ 2:51 PM
Study NCT ID:
NCT05723549
Status:
COMPLETED
Last Update Posted:
2023-09-22
First Post:
2023-02-02
Brief Title:
A Study to Evaluate the PK Safety and Tolerability of HCP1803
Sponsor:
Hanmi Pharmaceutical Company Limited
Organization:
Hanmi Pharmaceutical Company Limited
Study Overview
Official Title:
A Randomized Open-label Single-Dose Parallel Study to Evaluate the Pharmacokinetics Safety and Tolerability of HCP1803 in Healthy Male Volunteers
Status:
COMPLETED
Status Verified Date:
2023-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
A randomized open-label single-dose parallel study to evaluate the pharmacokinetics safety and tolerability of HCP1803 in healthy male volunteers
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None